|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.02 / 2.20|
Recently Completed Refinancing Transactions to Provide Company with up to $45 Million in Aggregate New Capital to Grow Company's Business
Transactions will Provide up to $45 Million in Aggregate New Capital to Grow Company's Business
Company Expects to Report Full Quarterly Financial Results and Host Conference Call on July 27, 2017
First Quarter Prescription Volumes Grew Year-Over-Year for Zohydro ER® with BeadTek™ and Silenor®
Fourth Quarter Prescription Volumes Grew Year-Over-Year for All Three Core Brands, Treximet®, Zohydro ER® with BeadTek™ and Silenor®
Regains Compliance with NASDAQ Listing Rule 5605(c)(2)(A)
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.